PERCEPTIVE ADVISORS LLC Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$6.5B
Holdings
145
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (145 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | 45,000,000 | $484.7B | 7479.67% | |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 3,283,783 | $481.7B | 7432.79% | |
| 3 | LIANYLIANBIO | 56,319,960 | $346.9B | 5353.28% | |
| 4 | AM6AMICUS THERAPEUTICS INC | 26,559,443 | $306.8B | 4733.46% | |
| 5 | SWTXSPRINGWORKS THERAPEUTICS INC | 4,849,912 | $300.6B | 4638.34% | |
| 6 | IOVAIOVANCE BIOTHERAPEUTICS INC | 10,127,941 | $193.3B | 2983.34% | |
| 7 | HZNPHORIZON THERAPEUTICS PUB L | 1,738,140 | $187.3B | 2890.13% | |
| 8 | —COLLEGIUM PHARMACEUTICAL INC | 17,500,000 | $169.3B | 2612.57% | |
| 9 | MGTXMEIRAGTX HLDGS PLC | 6,948,277 | $165.0B | 2545.27% | |
| 10 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 5,086,727 | $164.9B | 2544.64% | |
| 11 | CRNXCRINETICS PHARMACEUTICALS IN | 5,163,517 | $146.7B | 2263.58% | |
| 12 | —PROMETHEUS BIOSCIENCES INC | 3,172,785 | $125.5B | 1935.77% | |
| 13 | VAC2USDVBI VACCINES INC CDA | 52,335,002 | $122.5B | 1889.65% | |
| 14 | BBIOBRIDGEBIO PHARMA INC | 7,128,755 | $118.9B | 1834.78% | |
| 15 | OPHTEURIVERIC BIO INC | 6,480,000 | $108.3B | 1671.82% | |
| 16 | RAPTEURRAPT THERAPEUTICS INC | 2,927,565 | $107.5B | 1659.21% | |
| 17 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,180,000 | $104.3B | 1608.66% | |
| 18 | NVRO 2.75 04/01/25NEVRO CORP | 9,000,000 | $101.5B | 1566.49% | |
| 19 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 3,449,915 | $101.0B | 1558.15% | |
| 20 | CHRSCOHERUS BIOSCIENCES INC | 5,407,798 | $86.3B | 1331.77% | |
| 21 | OMGBPOUTSET MED INC | 1,863,397 | $85.9B | 1325.22% | |
| 22 | XENEXENON PHARMACEUTICALS INC | 2,411,447 | $75.3B | 1162.43% | |
| 23 | —LANDOS BIOPHARMA INC | 14,869,915 | $71.4B | 1101.34% | |
| 24 | CCCCC4 THERAPEUTICS INC | 2,208,913 | $71.1B | 1097.50% | |
| 25 | APLSAPELLIS PHARMACEUTICALS INC | 1,451,700 | $68.6B | 1059.08% | |
| 26 | BLUBELLUS HEALTH INC NEW | 7,645,234 | $61.5B | 949.65% | |
| 27 | —ZYMEWORKS INC | 3,679,845 | $60.3B | 930.64% | |
| 28 | RLAYRELAY THERAPEUTICS INC | 1,943,097 | $59.7B | 920.76% | |
| 29 | INBXUSDINHIBRX INC | 1,343,490 | $58.7B | 905.30% | |
| 30 | TVTXTRAVERE THERAPEUTICS INC | 1,845,555 | $57.3B | 883.95% | |
| 31 | BDQMALBIREO PHARMA INC | 2,360,139 | $55.0B | 848.18% | |
| 32 | CCXIEURCHEMOCENTRYX INC | 1,415,446 | $51.5B | 795.22% | |
| 33 | —COHERUS BIOSCIENCES INC | 4,500,000 | $51.5B | 794.50% | |
| 34 | NAUTNAUTILUS BIOTECHNOLOGY INC | 9,111,151 | $47.2B | 728.24% | |
| 35 | ARNAEURARENA PHARMACEUTICALS INC | 500,000 | $46.5B | 717.05% | |
| 36 | —ATHIRA PHARMA INC | 3,425,916 | $44.6B | 688.81% | |
| 37 | KODKODIAK SCIENCES INC | 520,152 | $44.1B | 680.45% | |
| 38 | —ICOSAVAX INC | 1,906,548 | $43.6B | 673.09% | |
| 39 | RCKTROCKET PHARMACEUTICALS INC | 1,959,125 | $42.8B | 659.93% | |
| 40 | —QUOTIENT LTD | 16,200,818 | $42.0B | 647.46% | |
| 41 | NBIXNEUROCRINE BIOSCIENCES INC | 483,007 | $41.1B | 634.78% | |
| 42 | MORFMORPHIC HLDG INC | 836,521 | $39.6B | 611.57% | |
| 43 | ALDXALDEYRA THERAPEUTICS INC | 9,903,879 | $39.6B | 611.29% | |
| 44 | —SINGULAR GENOMICS SYSTEMS IN | 3,333,824 | $38.5B | 594.67% | |
| 45 | —ISOPLEXIS CORP | 4,095,498 | $37.6B | 580.75% | |
| 46 | ACADACADIA PHARMACEUTICALS INC | 1,584,052 | $37.0B | 570.49% | |
| 47 | ZNTLZENTALIS PHARMACEUTICALS INC | 430,544 | $36.2B | 558.46% | |
| 48 | IMTXIMMATICS N.V | 2,500,000 | $33.6B | 518.46% | |
| 49 | PRCTPROCEPT BIOROBOTICS CORP | 1,328,285 | $33.2B | 512.60% | |
| 50 | VRCAVERRICA PHARMACEUTICALS INC | 3,610,412 | $33.1B | 510.30% | |
| 51 | KRON1USDKRONOS BIO INC | 2,421,142 | $32.9B | 507.71% | |
| 52 | —RAIN THERAPEUTICS INC | 2,483,619 | $32.0B | 493.60% | |
| 53 | TARSTARSUS PHARMACEUTICALS INC | 1,296,416 | $29.2B | 450.09% | |
| 54 | VRDNVIRIDIAN THERAPEUTICS INC | 1,423,053 | $28.1B | 434.12% | |
| 55 | LPTXEURLEAP THERAPEUTICS INC | 8,476,496 | $27.5B | 423.76% | |
| 56 | ESTAESTABLISHMENT LABS HLDGS INC | 405,541 | $27.4B | 422.96% | |
| 57 | COGTCOGENT BIOSCIENCES INC | 3,188,750 | $27.4B | 422.16% | |
| 58 | —CAREMAX INC | 3,549,525 | $27.3B | 420.63% | |
| 59 | MGNXMACROGENICS INC | 1,665,243 | $26.7B | 412.41% | |
| 60 | VERUEURVERU INC | 4,451,342 | $26.2B | 404.55% | |
| 61 | NUVBNUVATION BIO INC | 2,920,823 | $24.8B | 383.07% | |
| 62 | LUNGPULMONX CORP | 762,304 | $24.4B | 377.23% | |
| 63 | NVTA1EURINVITAE CORP | 1,584,585 | $24.2B | 373.37% | |
| 64 | SLDBSOLID BIOSCIENCES INC | 13,412,552 | $23.5B | 362.18% | |
| 65 | PYXSPYXIS ONCOLOGY INC | 1,944,114 | $21.3B | 329.07% | |
| 66 | HLTHQCUE HEALTH INC | 1,580,607 | $21.2B | 327.06% | |
| 67 | UTHUNITED THERAPEUTICS CORP DEL | 94,064 | $20.3B | 313.62% | |
| 68 | VRNAVERONA PHARMA PLC | 2,867,510 | $19.3B | 297.34% | |
| 69 | —SCIENCE 37 HOLDINGS INC | 1,500,000 | $18.7B | 288.63% | |
| 70 | ATNXEURATHENEX INC | 13,532,467 | $18.4B | 283.98% | |
| 71 | TMCITREACE MED CONCEPTS INC | 980,186 | $18.3B | 281.93% | |
| 72 | HCATHEALTH CATALYST INC | 454,004 | $18.0B | 277.56% | |
| 73 | —DICE THERAPEUTICS INC | 704,885 | $17.8B | 275.29% | |
| 74 | SLGCUSDSOMALOGIC INC | 1,500,000 | $17.5B | 269.41% | |
| 75 | ADMAADMA BIOLOGICS INC | 11,933,387 | $16.8B | 259.63% | |
| 76 | NUVLNUVALENT INC | 750,000 | $14.3B | 220.35% | |
| 77 | LYRALYRA THERAPEUTICS INC | 3,222,560 | $14.1B | 216.80% | |
| 78 | VTRSVIATRIS INC | 1,004,419 | $13.6B | 209.70% | |
| 79 | SAVACASSAVA SCIENCES INC | 300,000 | $13.1B | 202.29% | Put |
| 80 | BCABBIOATLA INC | 661,200 | $13.0B | 200.27% | |
| 81 | IMCRIMMUNOCORE HLDGS PLC | 360,000 | $12.3B | 190.20% | |
| 82 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 1,000,000 | $12.0B | 184.90% | |
| 83 | BIIBBIOGEN INC | 48,600 | $11.7B | 179.92% | |
| 84 | ABSIABSCI CORPORATION | 1,411,776 | $11.6B | 178.64% | |
| 85 | ACRSACLARIS THERAPEUTICS INC | 781,236 | $11.4B | 175.27% | |
| 86 | SMFRUSDSEMA4 HOLDINGS CORP | 2,500,000 | $11.2B | 172.05% | |
| 87 | MRUSMERUS N V | 350,000 | $11.1B | 171.74% | |
| 88 | IMRXIMMUNEERING CORP | 681,051 | $11.0B | 169.93% | |
| 89 | HYPRHYPERFINE INC | 1,500,000 | $10.9B | 167.81% | |
| 90 | GRPHGRAPHITE BIO INC | 850,093 | $10.6B | 163.05% | |
| 91 | CATBUSDASTRIA THERAPEUTICS INC | 1,959,652 | $10.6B | 162.98% | |
| 92 | —AGILE THERAPEUTICS INC | 21,294,485 | $10.4B | 160.38% | |
| 93 | HRMYHARMONY BIOSCIENCES HLDGS IN | 239,258 | $10.2B | 157.42% | |
| 94 | —SUMMIT HEALTHCRE ACQUISTN CO | 1,000,000 | $9.9B | 153.53% | |
| 95 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 352,804 | $9.9B | 152.76% | |
| 96 | KYMRKYMERA THERAPEUTICS INC | 155,000 | $9.8B | 151.85% | |
| 97 | —BCLS ACQUISITION CORP | 1,000,000 | $9.8B | 151.22% | |
| 98 | —RESEARCH ALLIANCE CORP II | 1,000,000 | $9.8B | 150.75% | |
| 99 | TYRATYRA BIOSCIENCES INC | 673,352 | $9.5B | 146.19% | |
| 100 | DAWNDAY ONE BIOPHARMACEUTICALS I | 556,047 | $9.4B | 144.57% |
Page 1 of 2Next